# NCT03639935 (NCT03639935)

> Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03639935
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: University of Michigan Rogel Cancer Center
- Conditions: Biliary Tract Cancer
- Interventions: Rucaparib; Nivolumab
- Enrollment: 32
- Primary outcome: Proportion of Patients Alive and Without Radiological or Clinical Progression at 4 Months

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct03639935